RNWHX
Price
$107.05
Change
-$0.71 (-0.66%)
Updated
Sep 11 closing price
Net Assets
90.01B
TSEMX
Price
$20.41
Change
+$0.16 (+0.79%)
Updated
Sep 11 closing price
Net Assets
2.31B
Interact to see
Advertisement

RNWHX vs TSEMX

RNWHX vs TSEMX Comparison Chart in %
View a ticker or compare two or three
VS
RNWHX vs. TSEMX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWHX is a StrongBuy and TSEMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 90B vs. TSEMX (2.31B). RNWHX pays higher dividends than TSEMX: RNWHX (1.15) vs TSEMX (0.70). RNWHX was incepted earlier than TSEMX: RNWHX (11 years) vs TSEMX (12 years). TSEMX (1.15) is less costly to investors than RNWHX (0.72). TSEMX is a more actively managed with annual turnover of: 51.00 vs. RNWHX (46.00). RNWHX has a lower initial minimum investment than TSEMX: RNWHX (250) vs TSEMX (2500). TSEMX annual gain was more profitable for investors over the last year : 20.69 vs. RNWHX (17.19). RNWHX return over 5 years is better than : 17.68 vs. TSEMX (-10.29).
RNWHXTSEMXRNWHX / TSEMX
Total Expense Ratio0.721.1563%
Annual Report Gross Expense Ratio0.721.1563%
Fund Existence11 years12 years-
Gain YTD16.44718.90887%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets90B2.31B3,894%
Annual Yield % from dividends1.150.70163%
Returns for 1 year17.1920.6983%
Returns for 3 years53.8452.34103%
Returns for 5 years17.68-10.29-172%
Returns for 10 years111.44104.44107%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLPEX46.310.28
+0.61%
Fidelity Advisor Low-Priced Stock C
FACDX64.25N/A
N/A
Fidelity Advisor Health Care A
EXHAX26.61N/A
N/A
Manning & Napier Pro-Blend Max Term S
LMCFX35.98N/A
N/A
Lord Abbett Mid Cap Stock F
MSAWX22.51N/A
N/A
Morgan Stanley Inst Asia Opp C